The information below may not include all possible side effects of these drugs
Still, Novo Nordisk is banking on the popularity of a higher-dose pill to treat both diabetes and obesity
It is believed that one way the incretin-based therapies induce weight loss is through activation of the neural pathways that regulate satiety and meal termination (e.g
and reporting of cardiovascular or renal outcomes
service as a consultant for AstraZeneca, Bayer Healthcare Pharmaceuticals, Biomea Fusion, Boehringer Ingelheim, Carmot, Eli Lilly, Intarcia, Intercept Pharmaceuticals, Janssen Global Services, Johnson & Johnson Medical Devices & Diagnostics GroupLatin America, MannKind Corporation, Merck, Novo Nordisk, Pfizer, Sanofi US Services, Shionogi, Structure Therapeutics, Target Pharma, Valeritas and Zealand Pharma A/S